vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $270.6M, roughly 1.2× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 3.4%, a 13.2% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 1.6%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $11.6M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 4.4%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
ALAB vs NGVC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $335.6M |
| Net Profit | $45.0M | $11.3M |
| Gross Margin | 75.6% | 29.5% |
| Operating Margin | 24.7% | 4.4% |
| Net Margin | 16.6% | 3.4% |
| Revenue YoY | 91.8% | 1.6% |
| Net Profit YoY | 82.0% | 14.0% |
| EPS (diluted) | $0.25 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $335.6M | ||
| Q3 25 | $230.6M | $336.1M | ||
| Q2 25 | $191.9M | $328.7M | ||
| Q1 25 | $159.4M | $335.8M | ||
| Q4 24 | $141.1M | $330.2M | ||
| Q3 24 | $113.1M | $322.7M | ||
| Q2 24 | $76.8M | $309.1M | ||
| Q1 24 | $65.3M | $308.1M |
| Q4 25 | $45.0M | $11.3M | ||
| Q3 25 | $91.1M | $11.8M | ||
| Q2 25 | $51.2M | $11.6M | ||
| Q1 25 | $31.8M | $13.1M | ||
| Q4 24 | $24.7M | $9.9M | ||
| Q3 24 | $-7.6M | $9.0M | ||
| Q2 24 | $-7.5M | $9.2M | ||
| Q1 24 | $-93.0M | $8.0M |
| Q4 25 | 75.6% | 29.5% | ||
| Q3 25 | 76.2% | 29.5% | ||
| Q2 25 | 75.8% | 29.9% | ||
| Q1 25 | 74.9% | 30.3% | ||
| Q4 24 | 74.0% | 29.9% | ||
| Q3 24 | 77.7% | 29.6% | ||
| Q2 24 | 77.9% | 29.2% | ||
| Q1 24 | 77.4% | 29.3% |
| Q4 25 | 24.7% | 4.4% | ||
| Q3 25 | 24.0% | 4.6% | ||
| Q2 25 | 20.7% | 4.7% | ||
| Q1 25 | 7.1% | 5.2% | ||
| Q4 24 | 0.1% | 4.0% | ||
| Q3 24 | -7.9% | 3.7% | ||
| Q2 24 | -31.7% | 4.2% | ||
| Q1 24 | -127.1% | 3.7% |
| Q4 25 | 16.6% | 3.4% | ||
| Q3 25 | 39.5% | 3.5% | ||
| Q2 25 | 26.7% | 3.5% | ||
| Q1 25 | 20.0% | 3.9% | ||
| Q4 24 | 17.5% | 3.0% | ||
| Q3 24 | -6.7% | 2.8% | ||
| Q2 24 | -9.8% | 3.0% | ||
| Q1 24 | -142.5% | 2.6% |
| Q4 25 | $0.25 | $0.49 | ||
| Q3 25 | $0.50 | $0.51 | ||
| Q2 25 | $0.29 | $0.50 | ||
| Q1 25 | $0.18 | $0.56 | ||
| Q4 24 | $1.23 | $0.43 | ||
| Q3 24 | $-0.05 | $0.38 | ||
| Q2 24 | $-0.05 | $0.40 | ||
| Q1 24 | $-1.77 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $23.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $220.0M |
| Total Assets | $1.5B | $668.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $23.2M | ||
| Q3 25 | $140.4M | $17.1M | ||
| Q2 25 | $162.3M | $13.2M | ||
| Q1 25 | $86.4M | $21.2M | ||
| Q4 24 | $79.6M | $6.3M | ||
| Q3 24 | $126.1M | $8.9M | ||
| Q2 24 | $421.1M | $13.9M | ||
| Q1 24 | $696.1M | $11.0M |
| Q4 25 | $1.4B | $220.0M | ||
| Q3 25 | $1.3B | $212.4M | ||
| Q2 25 | $1.1B | $202.5M | ||
| Q1 25 | $1.0B | $193.0M | ||
| Q4 24 | $964.8M | $181.9M | ||
| Q3 24 | $889.6M | $174.3M | ||
| Q2 24 | $845.3M | $167.8M | ||
| Q1 24 | $808.8M | $160.0M |
| Q4 25 | $1.5B | $668.6M | ||
| Q3 25 | $1.4B | $670.5M | ||
| Q2 25 | $1.3B | $659.0M | ||
| Q1 25 | $1.1B | $664.6M | ||
| Q4 24 | $1.1B | $648.9M | ||
| Q3 24 | $983.1M | $655.5M | ||
| Q2 24 | $915.5M | $654.4M | ||
| Q1 24 | $864.9M | $656.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $21.1M |
| Free Cash FlowOCF − Capex | $76.6M | $11.6M |
| FCF MarginFCF / Revenue | 28.3% | 3.4% |
| Capex IntensityCapex / Revenue | 6.9% | 2.9% |
| Cash ConversionOCF / Net Profit | 2.12× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $21.1M | ||
| Q3 25 | $78.2M | $15.6M | ||
| Q2 25 | $135.4M | $2.9M | ||
| Q1 25 | $10.5M | $34.1M | ||
| Q4 24 | $39.7M | $2.7M | ||
| Q3 24 | $63.5M | $24.5M | ||
| Q2 24 | $29.8M | $12.4M | ||
| Q1 24 | $3.7M | $20.2M |
| Q4 25 | $76.6M | $11.6M | ||
| Q3 25 | $65.9M | $7.5M | ||
| Q2 25 | $133.3M | $-4.2M | ||
| Q1 25 | $6.0M | $27.6M | ||
| Q4 24 | $24.3M | $-6.9M | ||
| Q3 24 | $46.8M | $18.0M | ||
| Q2 24 | $28.5M | $3.6M | ||
| Q1 24 | $228.0K | $9.8M |
| Q4 25 | 28.3% | 3.4% | ||
| Q3 25 | 28.6% | 2.2% | ||
| Q2 25 | 69.5% | -1.3% | ||
| Q1 25 | 3.7% | 8.2% | ||
| Q4 24 | 17.2% | -2.1% | ||
| Q3 24 | 41.4% | 5.6% | ||
| Q2 24 | 37.1% | 1.2% | ||
| Q1 24 | 0.3% | 3.2% |
| Q4 25 | 6.9% | 2.9% | ||
| Q3 25 | 5.3% | 2.4% | ||
| Q2 25 | 1.1% | 2.2% | ||
| Q1 25 | 2.8% | 1.9% | ||
| Q4 24 | 10.9% | 2.9% | ||
| Q3 24 | 14.8% | 2.0% | ||
| Q2 24 | 1.7% | 2.9% | ||
| Q1 24 | 5.2% | 3.4% |
| Q4 25 | 2.12× | 1.86× | ||
| Q3 25 | 0.86× | 1.32× | ||
| Q2 25 | 2.64× | 0.25× | ||
| Q1 25 | 0.33× | 2.60× | ||
| Q4 24 | 1.61× | 0.27× | ||
| Q3 24 | — | 2.72× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | — | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALAB
Segment breakdown not available.
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
